Landos Biopharma – Patient Worthy

Photo by Paweł Czerwiński on Unsplash

Study: BT-11 Produces Positive Results in Ulcerative Colitis

Post author:Kendall Mason
Post published:January 8, 2021
Post category:ulcerative Colitis

Landos Biopharma has recently released data from their Phase 2 trial of BT-11, a treatment for ulcerative colitis. The results were positive, making this therapy a possible viable treatment for…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More